Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1993-08-06
1996-04-02
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514178, 514179, 514180, 514177, A61K 3156
Patent
active
055040748
ABSTRACT:
The application discloses methods of treating mammalian diseases characterized by undesirable angiogenesis by administering estradiol derivatives including those comprising colchicine or combretastatin A-4 structural motifs of the general formulae found below in a dosage sufficient to inhibit cell mitosis. The application discloses novel compounds used in the methods.
REFERENCES:
patent: 4172132 (1979-10-01), Draper et al.
patent: 4522758 (1985-06-01), Ward et al.
patent: 4743597 (1988-05-01), Javitt et al.
patent: 5001116 (1991-03-01), Folkman et al.
Wheeler et al., Mutation Research vol. 171, pp. 31-41, 1986.
Chemical Abstract No. 54822z, "Mitotic inhibition and aneuploidy induction by naturally occurring and synthetic estrogens in Chinese hamster cells in vitro," vol. 105, No. 7, Aug. 18, 1986.
Boye et al., Helvetica Chimica Acta 72:1690-1696, 1989, "185. Deaminocolchinyl Methyl Ether: Synthesis from 2,3,4,4'-Tetramethoxybiphenyl-2-carbaldehyde. Comparison of Antitubulin . . . Analogs."
Crum et al., Science 230:1375-1378, 1985, "A New Class of Steroids Inhibits Angiogenesis in the Presence of Heparin or a Heparin Fragment."
Fitzgerald, Biochem. Pharmacol. 25:1383-1387, 1976, "Molecular Features of Colchicine Associated with Antimitotic Activity and Inhibition of Tubulin Polymerization."
Getahun et al., J. Med. Chem. 35:1058-1067, 1992, "Synthesis of Alkoxy-Substituted Diaryl Compounds and Correlation of Ring Separation with Inhibition of Tubulin Polymerization: . . . Conditions."
Hartley-Asp et al., Mutation Research 143:231-235, 1985, "Diethylstilbestrol induces metaphase arrest and inhibits microtubule assembly."
Huber et al., Bioorg. Med. Chem. Lett. 1:243-246, 1991, "Tubulin Binding of Conformationally Restricted Bis-Aryl Compounds."
Lin et al., Molecular Pharmacology 34:200-208, 1988, "Interactions of Tubulin with Potent Natural and Synthetic Analogs of the Antimitotic Agent Combretastatin: a Structure-Activity Study."
Lincoln et al., Biochemistry 30: 1179-1187, 1991, "Conformation of Thiocolchicine and Two B-Ring-Modified Analogues Bound to Tubulin Studied with optical Spectroscopy."
Lottering et al., Cancer Research 52:5926-5932, 1992, "Effects of 17.beta.-Extradiol Metabolites on Cell Cycle Events in MCF-7 Cells."
Nakamura et al., Chem. Pharm. Bull. 10:281-290, 1962, "Studies on the Total Synthesis of dl-Colchiceine. I. Synthesis of 3-Hydroxy-9,10,11-trimethoxy-1,2,3,4,6,7-hexahydro-5H-dibenzo a,c!cyclohep tatrien-5-one."
Paull et al., Cancer Research 52:3892-3900, 1992, "Identification of Novel Antimitotic Agents Acting at the Tubulin Level by Computer-assisted Evaluation of Differential Cytotoxicity Data."
Rao et al., Experimental Cell Research 48:71-81, 1967, "Structural Specificity of Estrogens in the Induction of Mitotic Chromatid Non-Disjunction in HeLa Cells."
Ravindra, J. Indian Inst. Sci. 64:27-35, 1983, "Effect of estradiol on the in vitro assembly of rat brain tubulin."
Sakakibara et al., Mutation Research 263:269-276, 1991, "Effects of diethylstilbestrol and its methyl ethers on aneuploidy induction and microtubule distribution in Chinese hamster V79 cells."
Sato et al., Chem. Pharm. Bull. 40:182-184, 1992, "Effect of Estradiol and Ethynylestradiol on Microtubule Distribution in Chinese Hamster V79 Cells."
Sato et al., Gann 75:1046-1048, 1984, "Disruptive Effect of Diethylstilbestrol on Microtubules."
Sawada et al., Mutation Research 57:175-182, 1978, "Colchicine-Like Effect of Diethylstilbestrol (DES) On Mammalian Cells In Vitro."
Seegers et al., J. steroid Biochem. 32:797-809, 1989, "The Cytotoxic Effects of Estradiol-17.beta., Catechol-estradiols and Methoxyestradiols on Dividing MCF-7 and HeLa Cells."
Sharp et al., Carcinogenes is 6:865-871, 1985, "Diethylstilboestrol: the binding and effects of diethylstilboestrol upon the polymerisation and depolymerisation of purified microtubule protein in vitro."
Spicer et al., Molecular and Cellular Endocrinology 64:119-126, 1989, "Catecholestrogens inhibit proliferation and DNA synthesis of porcine granulosa cells in vitro: . . . catecholamines."
Sternlicht et al., The Journal of Biological Chemistry 254:10540-10550, 1979, "Colchicine Inhibition of Microtubule Assembly via Copolymer Formation."
Seegers et al., Meeting Abstract of Joint NCI-Ist Symp. Third Ist Int'l Symp. Biology and Therapy of Breast Cancer. Sep. 25-27, 1989, Genoa, Italy, A58, 1989, "Cyclic-Amp and Cyclic-GMP Production . . . Cells."
Sun et al., J. Med. Chem. 36:544-551, 1993, "Antitumor Agnets. 139. Synthesis and Biological Evaluation of Thiocolchicine Analogs 5,6-Dihydro-6(S)-(acyloxy)-and 5,6-Dihydro-6(S)- (acroyloxy)methyl!-1,2,3 . . . ".
Sunagawa et al., Chem. Pharm. Bull. 9:81-83, 1961, "Synthesis of Colchicine; Syntehsis of dl-Demethyoxydeoxy-hexahydrocolchicine."
Tsutsui et al., Toxic. in Vitro 4:75-84, 1990, "Comparison of Human Versus Syrian Hamster Cells in Culture for Induction of Mitotic Inhibition, Binucleation and Multinucleation, Following Treatment with Four . . . ".
van Tamelen et al., Tetrahedron 14:8-34, 1961, "The Synthesis of Colchicine."
Wheeler et al., Cytoskel. 7:235-247, 1987, "Mitotic Inhibition and Chromosome Displacement Induced by Estradiol in Chinese Hamster Cells."
Oppolzer et al., Helvetica Chimica Acta 63:1703-1707, 1980, "177. The Enantioselective Synthesis of (+)-Estradiol from 1,3-Dihydrobenzo c!thiophene-2,2-dioxide by Sucessive Thermal S02-Extrusion . . . Reactions."
Research Plus Catalogue, pp. 50-58, 1993.
Gross et al., Proc. Natl. Acad. Sci. USA 78:1176-1180, 1981, "Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone."
Poli et al., Proc. Natl. Acad. Sci. USA 87:782-785, 1990, "Tumor necrosis factor .alpha. functions in an autocrine manner in the unduction of human immunodeficiency virus expression."
Evans et al., J. Am. Chem. Society 103:5813-5821, 1981, "A Convergent Total Synthesis of (.+-.)-Colchicine and (.+-.)-Desacetamidoisocolchicine."
CA104:142406, Ochs et al, Cancer Res., 46(3) 1224-32, 1986.
CA86:452863, Yasuda et al, Anat. Embroyol, 174(3), 1986, 289-300.
BA93:119738, Mayol et al, Carcinogenesis, 13(12) 1992, 2381-2388.
D'Amato Robert J.
Folkman Moses J.
Children's Medical Center Corporation
Cook Rebecca
LandOfFree
Estrogenic compounds as anti-angiogenic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Estrogenic compounds as anti-angiogenic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrogenic compounds as anti-angiogenic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2016380